Objective
A major issue in the translation of findings from mouse models to clinical practice is the lack of appropriate tools to identify causal mechanisms of oncogenesis, tumor progression, and drug activity. The multidisciplinary project here proposed will characterize fundamental mechanisms and signaling pathways deregulated in prostate cancer through the assembly of a prostate cancer interactome, which is an accurate network of transcriptional and post-translational molecular interactions. Importantly, we will utilize reverse-engineering approaches that are unbiased and encompass the entire genome. We will use gene expression profiling of samples from different mouse models in order to have a representation of all the stages of the disease. This novel mouse to human paradigm will allow distinguishing the “drivers” of prostate cancer from the large number of “passenger” genes whose expression is coincidentally rather than causally altered in cancer progression. Key regulators will then be validated by expression analyses in mouse and human prostate cancers tissue micro-arrays to assess their relationship to disease aggressiveness and outcome. Finally, interrogation of this interactome will allow the identification of novel druggable targets for prostate cancer therapy. Candidate targets will be identified focusing first on those genes that can modulate particular signaling pathways deregulated in prostate cancer, and second on candidate targets that may induce tumor-cell specific apoptosis. Next, we will validate the expression of these candidate targets in human prostate cancer specimens, thus allowing the identification of the individuals that might benefit from specific interventions. The integrated in vivo modeling and bioinformatics study on prostate cancer proposed here will improve the capacity of the European host institution of conducting cutting edge research on this area and should constitute a significant step forward in the European leadership in the field.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences clinical medicine oncology prostate cancer
- natural sciences biological sciences genetics genomes
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2009-IOF
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
08908 L'Hospitalet De Llobregat
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.